Annual CFO
-$135.50 M
-$50.10 M-58.67%
December 31, 2024
Summary
- As of March 13, 2025, AVIR annual cash flow from operations is -$135.50 million, with the most recent change of -$50.10 million (-58.67%) on December 31, 2024.
- During the last 3 years, AVIR annual CFO has fallen by -$48.49 million (-55.74%).
- AVIR annual CFO is now -145.66% below its all-time high of $296.73 million, reached on December 31, 2020.
Performance
AVIR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$30.40 M
-$7.36 M-31.96%
December 31, 2024
Summary
- As of March 13, 2025, AVIR quarterly cash flow from operations is -$30.40 million, with the most recent change of -$7.36 million (-31.96%) on December 31, 2024.
- Over the past year, AVIR quarterly CFO has dropped by -$8.56 million (-39.22%).
- AVIR quarterly CFO is now -109.54% below its all-time high of $318.52 million, reached on December 31, 2020.
Performance
AVIR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$135.50 M
-$8.56 M-6.75%
December 31, 2024
Summary
- As of March 13, 2025, AVIR TTM cash flow from operations is -$135.50 million, with the most recent change of -$8.56 million (-6.75%) on December 31, 2024.
- Over the past year, AVIR TTM CFO has dropped by -$50.10 million (-58.67%).
- AVIR TTM CFO is now -144.15% below its all-time high of $306.94 million, reached on September 30, 2021.
Performance
AVIR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AVIR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.7% | -39.2% | -58.7% |
| 3 y3 years | -55.7% | -72.8% | -59.2% |
| 5 y5 years | -956.2% | -72.8% | -59.2% |
AVIR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.7% | at low | -88.6% | +59.7% | -59.2% | +22.5% |
| 5 y | 5-year | -145.7% | at low | -109.5% | +59.7% | -144.2% | +22.5% |
| alltime | all time | -145.7% | at low | -109.5% | +59.7% | -144.2% | +22.5% |
Atea Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$135.50 M(+58.7%) | -$30.40 M(+32.0%) | -$135.50 M(+6.7%) |
| Sep 2024 | - | -$23.04 M(-45.4%) | -$126.94 M(+4.5%) |
| Jun 2024 | - | -$42.20 M(+5.9%) | -$121.49 M(+27.3%) |
| Mar 2024 | - | -$39.87 M(+82.6%) | -$95.41 M(+11.7%) |
| Dec 2023 | -$85.39 M(-29.4%) | -$21.83 M(+24.1%) | -$85.39 M(+0.3%) |
| Sep 2023 | - | -$17.59 M(+9.1%) | -$85.11 M(-4.1%) |
| Jun 2023 | - | -$16.12 M(-46.0%) | -$88.76 M(-3.3%) |
| Mar 2023 | - | -$29.85 M(+38.5%) | -$91.82 M(-24.1%) |
| Dec 2022 | -$120.98 M | -$21.55 M(+1.4%) | -$120.98 M(-30.8%) |
| Sep 2022 | - | -$21.24 M(+10.7%) | -$174.86 M(+33.5%) |
| Jun 2022 | - | -$19.19 M(-67.5%) | -$131.01 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$59.01 M(-21.8%) | -$129.18 M(+48.5%) |
| Dec 2021 | -$87.00 M(-129.3%) | -$75.42 M(-433.7%) | -$87.00 M(-128.3%) |
| Sep 2021 | - | $22.60 M(-230.3%) | $306.94 M(+11.7%) |
| Jun 2021 | - | -$17.35 M(+3.0%) | $274.86 M(-3.4%) |
| Mar 2021 | - | -$16.84 M(-105.3%) | $284.40 M(-4.2%) |
| Dec 2020 | $296.73 M(-2413.0%) | $318.52 M(-3459.6%) | $296.73 M(-1462.0%) |
| Sep 2020 | - | -$9.48 M(+21.6%) | -$21.79 M(+77.0%) |
| Jun 2020 | - | -$7.80 M(+73.0%) | -$12.31 M(+173.0%) |
| Mar 2020 | - | -$4.51 M | -$4.51 M |
| Dec 2019 | -$12.83 M(+62.2%) | - | - |
| Dec 2018 | -$7.91 M | - | - |
FAQ
- What is Atea Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual CFO year-on-year change?
- What is Atea Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly CFO year-on-year change?
- What is Atea Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals TTM CFO year-on-year change?
What is Atea Pharmaceuticals annual cash flow from operations?
The current annual CFO of AVIR is -$135.50 M
What is the all time high annual CFO for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual cash flow from operations is $296.73 M
What is Atea Pharmaceuticals annual CFO year-on-year change?
Over the past year, AVIR annual cash flow from operations has changed by -$50.10 M (-58.67%)
What is Atea Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AVIR is -$30.40 M
What is the all time high quarterly CFO for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly cash flow from operations is $318.52 M
What is Atea Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AVIR quarterly cash flow from operations has changed by -$8.56 M (-39.22%)
What is Atea Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AVIR is -$135.50 M
What is the all time high TTM CFO for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high TTM cash flow from operations is $306.94 M
What is Atea Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AVIR TTM cash flow from operations has changed by -$50.10 M (-58.67%)